Related Experiment Videos
Frequently nebulized beta-agonists for asthma: effects on serum electrolytes
J Bodenhamer1, R Bergstrom, D Brown
1Emergency Medical Services, Denver General Hospital.
Annals of Emergency Medicine
|November 1, 1992
Summary
Repeated doses of albuterol for acute bronchospasm significantly lowered serum potassium, magnesium, and phosphate levels in patients. These electrolyte changes occurred during emergency treatment and require further investigation.
Area of Science:
- Emergency Medicine
- Pulmonology
- Clinical Chemistry
Background:
- Acute bronchospasm necessitates prompt treatment with beta-adrenergic agonists.
- Aggressive administration protocols for these agents are common in emergency settings.
Purpose of the Study:
- To quantify the changes in serum electrolytes (potassium, magnesium, phosphate) during intensive albuterol treatment for acute bronchospasm.
Main Methods:
- A prospective study was conducted in an emergency department involving 23 adult patients with acute bronchospasm.
- Serum electrolyte levels and peak expiratory flow rate were measured at baseline and serially after repeated nebulized albuterol (2.5 mg) every 30 minutes.
Main Results:
- Significant decreases (P = .0001) were observed in serum potassium, magnesium, and phosphate levels over 180 minutes of treatment.
- Potassium dropped below 3.0 mmol/L in 22% of patients.
- Mean serum potassium decreased from 4.10 to 3.45 mmol/L, magnesium from 1.64 to 1.40 mmol/L, and phosphate from 3.74 to 2.55 mmol/L.
Conclusions:
- Intensive nebulized albuterol therapy for acute bronchospasm is associated with significant reductions in serum potassium, magnesium, and phosphate.
- The clinical implications and underlying mechanisms of these electrolyte shifts warrant further research.